Paclitaxel Drug Market

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
Paclitaxel Drug Market aims to provide a comprehensive presentation of the global market for Paclitaxel Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Paclitaxel Drug. Paclitaxel Drug Market contains market size and forecasts of Paclitaxel Drug in global, including the following market information:
Global Paclitaxel Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Paclitaxel Drug Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Paclitaxel Drug companies in 2022 (%)
The global Paclitaxel Drug market was valued at US$ 121 million in 2022 and is projected to reach US$ 141.9 million by 2029, at a CAGR of 2.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.
We surveyed the Paclitaxel Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Paclitaxel Drug Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Paclitaxel Drug Market Segment Percentages, by Type, 2022 (%)
30mg
100mg
Global Paclitaxel Drug Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Paclitaxel Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Drugs Store
Global Paclitaxel Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Paclitaxel Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Paclitaxel Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Paclitaxel Drug revenues share in global market, 2022 (%)
Key companies Paclitaxel Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Paclitaxel Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Luye Pharma
CSPC Company
Celgene
Jiangsu Hengrui
Bristol-Myers Squibb
Pfizer
Teva
Mylan
Novartis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Paclitaxel Drug, market overview.
Chapter 2: Global Paclitaxel Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Paclitaxel Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Paclitaxel Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Paclitaxel Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.